Abstract

Adenomatous polyposis coli gene product (APC) functions as a tumor suppressor and its mutations in familial adenomatous polyposis and colorectal cancers lead to the accumulation of cytoplasmic beta-catenin. The molecular mechanism by which APC regulates the stability of beta-catenin was investigated. The central region of APC, APC-(1211-2075), has the beta-catenin- and Axin-binding sites and down-regulates beta-catenin. Glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylated beta-catenin slightly in the presence of either APC-(1211-2075) or Axin(delta)(beta)(-catenin), in which the beta-catenin-binding site is deleted, and greatly in the presence of both proteins. The enhancement of the GSK-3 beta-dependent phosphorylation of beta-catenin was eliminated by the APC-binding site of Axin. Axin down-regulated beta-catenin in SW480 cells, but not Axin(delta)(beta)(-catenin). In L cells where APC is intact, Axin(delta)(beta)(-catenin) inhibited Wnt-dependent accumulation of beta-catenin but not Axin-(298-832)(delta)(beta)(-catenin) in which the APC- and beta-catenin-binding sites are deleted. These results indicate that the complex formation of APC and Axin enhances the phosphorylation of beta-catenin by GSK-3 beta, leading to the down-regulation of beta-catenin.

Highlights

  • APC1 is a tumor suppressor linked to FAP and to the initiation of sporadic human colorectal cancer [1]

  • Failure of Ubiquitination of ␤-Catenin in SW480 Cells—It has been demonstrated that the ubiquitin-proteasome pathway degrades ␤-catenin and that the phosphorylation of ␤-catenin by GSK-3␤ is required for its ubiquitination [33, 34]

  • Since ␤-catenin is accumulated in SW480 cells, human colon cancer cell lines where the C-terminal half of Adenomatous polyposis coli gene product (APC) is truncated, we first examined whether the ubiquitination of ␤-catenin occurs in the cells

Read more

Summary

Introduction

APC1 is a tumor suppressor linked to FAP and to the initiation of sporadic human colorectal cancer [1]. The enhancement of the GSK-3␤-dependent phosphorylation of ␤-catenin was eliminated by the APC-binding site of Axin. We show that APC promotes GSK-3␤-dependent phosphorylation of ␤-catenin by interacting with Axin, thereby down-regulating ␤-catenin.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.